aTyr Pharma, Inc. (LIFE): Price and Financial Metrics
LIFE Price/Volume Stats
Current price | $1.90 | 52-week high | $2.45 |
Prev. close | $1.85 | 52-week low | $1.08 |
Day low | $1.82 | Volume | 269,400 |
Day high | $1.95 | Avg. volume | 514,103 |
50-day MA | $1.76 | Dividend yield | N/A |
200-day MA | $1.59 | Market Cap | 131.12M |
LIFE Stock Price Chart Interactive Chart >
aTyr Pharma, Inc. (LIFE) Company Bio
aTyr Pharma, Inc. is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology. aTyr research and development focuses on the extracellular functionality and signaling pathways of tRNA synthetases. Over the last ten years, the company has developed an international portfolio of intellectual property, including 20 human tRNA synthetases and over 300 protein compositions patented. Sanjay S. Shukla, M.D., M.S. has served as our President and Chief Executive Officer and as a board member since November 2017. aTyr’s headquarters is located in San Diego, California and the company employs 42 people.
LIFE Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | 5.56% |
1-year | 62.39% |
3-year | -76.25% |
5-year | -54.87% |
YTD | 34.75% |
2023 | -35.62% |
2022 | -70.68% |
2021 | 92.53% |
2020 | -6.95% |
2019 | -39.95% |
Continue Researching LIFE
Want to see what other sources are saying about aTYR PHARMA INC's financials and stock price? Try the links below:aTYR PHARMA INC (LIFE) Stock Price | Nasdaq
aTYR PHARMA INC (LIFE) Stock Quote, History and News - Yahoo Finance
aTYR PHARMA INC (LIFE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...